Magnetic resonance imaging in social phobia

Recent studies have implicated dopamine and the basal ganglia circuits in the pathophysiology of social phobia. Twenty-two patients who met DSM-III-R criteria for social phobia and 22 age- and sex-matched control subjects underwent magnetic resonance imaging (MRI). MRI was performed with a 1.5 Tesla General Electric Signa System. No statistically significant difference was demonstrated between social phobia patients and normal control subjects in respect to total cerebral, caudate, putamen, and thalamic volumes. Although this study failed to demonstrate any specific cerebral structure abnormalities in patients with social phobia, it did reveal an age-related reduction in putamen volumes in patients with social phobia that was greater than that seen in controls. This age-related reduction in putamen volumes in patients with social phobia was not correlated with the severity of their illness.

[1]  R. Raguram,et al.  Patterns of Phobic Neurosis: A Retrospective Study , 1985, British Journal of Psychiatry.

[2]  R. Mailman,et al.  Social Reactivity and D1 Dopamine Receptors: Studies in Mice Selectively Bred for High and Low Levels of Aggression , 1994, Neuropsychopharmacology.

[3]  I. Mefford,et al.  CSF dopamine levels correlate with extraversion in depressed patients , 1986, Psychiatry Research.

[4]  E. Hollander,et al.  MAOIs: Impact on social behavior , 1987, Psychiatry Research.

[5]  Schneider Js Basal ganglia role in behavior: importance of sensory gating and its relevance to psychiatry. , 1984 .

[6]  E. Hollander,et al.  Buspirone in social phobia. , 1993, Journal of clinical psychopharmacology.

[7]  Lauterbach Ec,et al.  Anxiety disorders in familial parkinsonism. , 1991 .

[8]  M. Tancer,et al.  Phenomenology and neurobiology of social phobia: comparison with panic disorder. , 1991, The Journal of clinical psychiatry.

[9]  J. Deltito,et al.  Psychopharmacological treatment of avoidant personality disorder. , 1989, Comprehensive psychiatry.

[10]  H. Sternbach Fluoxetine treatment of social phobia. , 1990, Journal of clinical psychopharmacology.

[11]  J. Gorman,et al.  Epinephrine infusions in patients with social phobia. , 1988, The American journal of psychiatry.

[12]  M. Weissman,et al.  Social Phobia: Comorbidity and Morbidity in an Epidemiologic Sample , 1992 .

[13]  M. Gelder,et al.  Social Phobia: A Comparative Clinical Study , 1983, British Journal of Psychiatry.

[14]  M M Weissman,et al.  Six-month prevalence of psychiatric disorders in three communities 1980 to 1982. , 1984, Archives of general psychiatry.

[15]  F. W. Brown,et al.  White matter hyperintensity signals in psychiatric and nonpsychiatric subjects. , 1992, The American journal of psychiatry.

[16]  D. Cohen,et al.  School avoidance and social phobia triggered by haloperidol in patients with Tourette's disorder. , 1981, The American journal of psychiatry.

[17]  K. Krishnan,et al.  In vivo stereological assessment of human cerebellar volume: effects of gender and age. , 1991, AJNR. American journal of neuroradiology.

[18]  I. Heuser,et al.  Anxiety disorders in patients with Parkinson's disease. , 1990, The American journal of psychiatry.

[19]  K. Krishnan,et al.  In vivo stereological assessment of caudate volume in man: effect of normal aging. , 1990, Life sciences.

[20]  J. Davidson,et al.  The epidemiology of social phobia: findings from the Duke Epidemiological Catchment Area Study , 1993, Psychological Medicine.

[21]  K. Krishnan,et al.  The Brief Social Phobia Scale. , 1991, The Journal of clinical psychiatry.

[22]  H. E. Rosvold,et al.  Behavioral effects of selective ablation of the caudate nucleus. , 1967, Journal of comparative and physiological psychology.

[23]  M. Stein,et al.  Effects of thyrotropin-releasing hormone on blood pressure and heart rate in phobic and panic patients: A pilot study , 1990, Biological Psychiatry.

[24]  J. Gorman,et al.  Specificity of lactate infusions in social phobia versus panic disorders. , 1985, The American journal of psychiatry.